Aurobindo Pharma to invest Rs 300 crore on mammalian cell culture manufacturing facility
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The company will be holding 26% of the share capital in each of the solar power generating companies.
Subscribe To Our Newsletter & Stay Updated